Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients
Author:
Affiliation:
1. Division of Vascular Medicine; Department of Internal Medicine; Medical University of Graz; Graz Austria
2. Division of Oncology; Department of Internal Medicine; Medical University of Graz; Graz Austria
Publisher
Hindawi Limited
Subject
General Medicine
Reference23 articles.
1. Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary event;Bertomeu;Eur J Vasc Endovasc Surg,2008
2. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration;Andersson;Thromb Res,1976
3. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;J Vasc Surg,2007
4. Critical limb ischemia: definition and natural history;Novo;Curr Drug Targets Cardiovasc Haematol Disord,2004
5. Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group;Bertele;Eur J Vasc Endovasc Surg,1999
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of lymphocyte-to-monocyte ratio as a predictive marker for diabetic coronary artery disease: A cross-sectional study;World Journal of Methodology;2024-09-20
2. Comparison Of The Relationship Between Inflammatory Markers And Saphenous Vein Graft Disease In Patients With Stable Angina Pectoris.;Acta Medica Alanya;2023-12-31
3. The Preoperative Lymphocyte-To-Monocyte Ratio Predicts Mortality Among Patients Undergoing Endovascular Aortic Repair for Abdominal Aortic Aneurysm;Vascular and Endovascular Surgery;2023-10-03
4. Selection of Monocyte-to-Lymphocyte Ratio (MLR) or Lymphocyte-to-Monocyte Ratio (LMR) as Best Prognostic Tool in Heart Failure: a Systematic Review;SN Comprehensive Clinical Medicine;2023-09-20
5. Prognostic value of monocyte-to-lymphocyte ratio for 90-day all-cause mortality in type 2 diabetes mellitus patients with chronic kidney disease;Scientific Reports;2023-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3